Aspirin inhibits lipopolysaccharide-induced COX-2 expression and PGE2production in porcine alveolar macrophages by modulating protein kinase C and protein tyrosine phosphatase activity
Authors:
- Yuzhong DuanYDYuzhong Duan
- Fanglin ChenFCFanglin Chen
- Anmei ZhangAZAnmei Zhang
- Bo ZhuBZBo Zhu
- Jianguo SunJSJianguo Sun
- Qichao XieQXQichao Xie
- Zhengtang ChenZCZhengtang Chen
Open Access
- 31 January 2014
- journal article
- Published by Korean Society for Biochemistry and Molecular Biology - BMB Reports in BMB Reports
- Vol. 47 (1) , 45-50
Abstract
Aspirin has been demonstrated to be effective in inhibiting COX-2 and PGE2 in Alveolar macrophages (AMs). However, the mechanisms have not been fully understood. In the present study, we found that pretreatment with aspirin inhibited LPS-induced COX-2 and PGE2 upregulation, IκBα degradation, NFκB activation and the increase of PKC activity, but elevated LPS-induced the decrease of PTP activity. The PKC inhibitor calphostin C dramatically reduced the COX-2 mRNA and PGE2 levels, but the PTP inhibitor peroxovanadium (POV) significantly increased the COX-2 mRNA and PGE2 levels. Furthermore, the PTP inhibitor mitigated the inhibitory effect of aspirin on COX-2 and PGE2 upregulation and NF-κB activation, whereas the PKC inhibitor enhanced the inhibitory effects of aspirin on the production of COX-2 and PGE2. Our data indicate a novel mechanism by which aspirin acts as a potent anti-inflammatory agent in alveolus macrophages and ALI. [BMB Reports 2014; 47(1): 45-50]Keywords
This publication has 29 references indexed in Scilit:
- Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injuryJournal of Clinical Investigation, 2009
- Animal models of acute lung injuryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Pulmonary and extrapulmonary acute respiratory distress syndrome: myth or reality?Current Opinion in Critical Care, 2008
- BK-induced COX-2 expression via PKC-δ-dependent activation of p42/p44 MAPK and NF-κB in astrocytesCellular Signalling, 2007
- Posttreatment with Aspirin-Triggered Lipoxin A4 Analog Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Mice: The Role of Heme Oxygenase-1Anesthesia & Analgesia, 2007
- Aspirin-Mediated COX-2 Transcript Stabilization via Sustained p38 Activation in Human Intestinal MyofibroblastsMolecular Pharmacology, 2004
- Sodium salicylate inhibits expression of COX-2 through suppression of ERK and subsequent NF-κB activation in Rat ventricular cardiomyocytesArchives of Pharmacal Research, 2003
- Aspirin inhibits NF‐κB and protects from angiotensin II‐induced organ damageThe FASEB Journal, 2001
- How NF-κB is activated: the role of the IκB kinase (IKK) complexOncogene, 1999
- Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB ActivationScience, 1996